The Ohio State University 2012 - 2014
Masters, Master of Arts, Japanese Language, Literature, Japanese Language and Literature
Beijing Normal University 2008 - 2011
Masters, Master of Arts, Japanese Literature
Tokyo Gakugei University 2009 - 2010
Beijing Normal University 2004 - 2008
Bachelors, Bachelor of Arts, Japanese Language, Literature, Japanese Language and Literature
Texas Tech University
Benxi High School
Skills:
Japanese Language Proficiency Test Teaching Microsoft Office Teamwork Microsoft Word Chinese Mandarin Powerpoint Research Social Media University Teaching English Public Speaking Higher Education
Interests:
Table Tennis Sports and Outdoor Activities Travelling Hiking Tennis Swimming
Aug 2013 to 2000 Lead Architect Distributed Technology ServicesFinancial Risk Technology, GOLDMAN SACHS New York, NY Jan 2011 to Jul 2013 Solution ArchitectEnterprise Technology, GOLDMAN SACHS Jersey City, NJ 2008 to 2011 Team Lead/Project ManagerSecurities Division, GOLDMAN SACHS New York, NY 2005 to 2008 Senior System EngineerTrading Division, GOLDMAN SACHS New York, NY 2001 to 2005 System Administrator
Education:
New York University New York, NY May 2010 Masters in Business AdministrationUniversity of Pennsylvania Philadelphia, PA May 2001 M.S. in Telecommunications and NetworkingBeijing Institute of Technology Jun 1996 B.S. in Engineering
Stevens Institute of Technology Hoboken, NJ Sep 2007 to Dec 2011 Teaching Assistant
Education:
Stevens Institute of Technology Hoboken, NJ Jan 2007 to Jan 2011 Master of Science in PhysicsStevens Institute of Technology Hoboken, NJ Jan 2007 to Jan 2011 Master of Engineering in Engineering Optics
Emma R. Parmee - Scotch Plains NJ, US Yusheng Xiong - Plainsboro NJ, US Jian Guo - Scotch Plains NJ, US Rui Liang - East Brunswick NJ, US Linda Brockunier - Orange NJ, US
Assignee:
Merck & Co., Inc - Rahway NJ
International Classification:
A61K 31/416 C07D 231/02
US Classification:
514406, 5483771, 5483644
Abstract:
Pyrazoles having a naphthyl group attached are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Substituted Pyrazoles, Compositions Containing Such Compounds And Methods Of Use
Linda Brockunier - Orange NJ, US Jian Guo - Scotch Plains NJ, US Rui Liang - East Brunswick NJ, US Emma R. Parmee - Scotch Plains NJ, US Subharekha Raghavan - Teaneck NJ, US George Scott Tria - Princeton NJ, US Yusheng Xiong - Plainsboro NJ, US
The present invention relates to substituted pyrazoles, compositions containing such compounds and methods of treatment. The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.
Pyrazole Derivatives, Compositions Containing Such Compounds And Methods Of Use
Emma R. Parmee - Scotch Plains NJ, US Yusheng Xiong - Plainsboro NJ, US Jian Guo - Scotch Plains NJ, US Rui Liang - East Brunswick NJ, US Linda Brockunier - Orange NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/415 A61K 31/4162 C07D 231/10
US Classification:
514406, 5483771, 544350, 514249
Abstract:
Pyrazoles having a naphthyl group attached are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Sanyog Pendharkar - Old Bridge NJ, US Jian Guo - Bridgewater NJ, US
International Classification:
A61F015/00 B32B027/12
US Classification:
424/445000, 442/123000
Abstract:
The present invention is directed to a hemostatic wound dressing that utilizes a fibrous, fabric substrate made from a biocompatible polymer and containing a first wound-contacting surface and a second surface opposing the first surface, the fabric having flexibility, strength and porosity effective for use as a hemostat; and further having a porous, polymeric matrix distributed at least on the first surface and through the fabric, the porous, polymeric matrix being made of a biodegradable biocompatible, water-soluble or water-swellable aldehyde-oxidized polysaccharide.
Pyrazole Derivatives, Compositions Containing Such Compounds And Methods Of Use
Emma Parmee - Scotch Plains NJ, US Yusheng Xiong - Plainsboro NJ, US Jian Guo - Scotch Plains NJ, US Linda Brockunier - Orange NJ, US
International Classification:
A61K 31/415 C07D 231/12
US Classification:
514406000, 548377100
Abstract:
Pyrazoles having a naphthyl group attached are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Linda L. Brockunier - Orange NJ, US Jian Guo - Scotch Plains NJ, US Emma R. Parmee - Scotch Plains NJ, US Subharekha Raghavan - Teaneck NJ, US Keith Rosauer - Laurence Harbor NJ, US Darby Schmidt - Arlington MA, US John E. Stelmach - Westfield NJ, US
Compounds of Formula I are capable of modulating the body's production of cyclic guanosine monophosphate (“cGMP”) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of the Formula I, to their use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of the Formula I.
Subharekha Raghavan - Teaneck NJ, US John E. Stelmach - Westfield NJ, US Cameron J. Smith - Lawrenceville NJ, US Hong Li - Edison NJ, US Alan Whitehead - Scotch Plains NJ, US Sherman T. Waddell - Westfield NJ, US Yi-Heng Chen - Whippany NJ, US Shouwu Miao - Edison NJ, US Olga A. Ornoski - Teaneck NJ, US Joie Garfunkle - Metuchen NJ, US Xibin Liao - Edison NJ, US Jiang Chang - Westfield NJ, US Xiaoqing Han - Edison NJ, US Jian Guo - Scotch Plains NJ, US Jonathan A. Groeper - Metuchen NJ, US Linda L. Brockunier - Orange NJ, US Keith Rosauer - New Hampton IA, US Emma R. Parmee - Doylestown PA, US
A compound of Formula (I): or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate (“cGMP”) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of Formula (I) or a pharmaceutically acceptable salt thereof.
News
Germany arrests woman who allegedly passed airport details to suspected spy for China
They alleged that, between August 2023 and mid-February this year, she repeatedly passed information to Jian Guo a German national who was an aide to far-right European Parliament lawmaker Maximilian Krah and was arrested in April. That, prosecutors said, included above all information on the tran